Navigation Links
CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market
Date:4/13/2009

According to CBDM.T®, the market and business intelligence company, the vaccine market is a huge and growing market valued at 16 billion in 2008 with an annual growth of about 15 to 18%. The vaccine market could account for more than 25 billion by 2012.

Paris, France (PRWEB) April 13, 2009 -- Vaccines are substances used to stimulate the production of antibodies and provide immunity against one or several diseases. The vaccination was first used by Edward Jenner in 1796 against smallpox and furthered by Louis Pasteur in the 1870's. Vaccines are developed from whole dead or attenuated organisms, pathogen protein toxin (toxoids), pathogen surface molecules, inactivated or attenuated virus and more recently from DNA plasmid carrying an antigen-coding gene.

According to CBDM.T, vaccines represent one of the fastest growing pharmaceutical product categories at over 17% per annum to 2012. This is driven largely by strong growth of HPV vaccines (Human Papilloma Virus,Cervarix and Gardasil), paediatric vaccines (Rotarix) launched into developing markets and meningitis vaccines (Prevnar, Menactra), the successful life cycle management of combination vaccines such as Pentacel and Infanrix, and expansion of the flu market. Childhood vaccines are the main segment, accounting for around 56% of the global vaccine market.

In 2008, 220 vaccines were under development from discovery (84 products), preclinical (39 products), clinical phase 1 (36 products), clinical phase 2 (50 products) to clinical phase 3 (with 14 products). 17 products were on the market. The leading top 5 pharmaceutical companies in this market are Sanofi-Aventis, GSK, Wyeth, Merck and Novartis (Chiron).

Vaccines are big business. According to CBDM.T®, the vaccine market is a huge and growing market valued at 16 billion in 2008 with an annual growth of about 15 to 18%. USA sales account for 45% of total vaccine sales. The vaccine market could account for more than 25 billion by 2012. If we look at the top 5 pharmaceutical companies, vaccine sales represent between 8 to 9% of their total sales. The top 20 vaccines brands account for 80% of total vaccine sales. Large companies have recently attempted to acquire market share. In 2005, Novartis bought Chiron's remaining 58% for $5.1 billion (now making 100%). "Vaccines continue to emerge as significant value drivers for major pharma. A promising alternative to conventional vaccines, DNA vaccines, is under late clinical phase development" comments Philippe Tramoy, managing partner.

Key players: Sanofi-Aventis, Sanofi-Pasteur, GSK, Wyeth, Merck, Norvartis, Chiron, Avax Technologies, CSL Biotherapies, Omrix biopharmaceuticals, Epimmune, Oxxon Therapeutics, Vical, Fit Biotech, Genencor, Innogenetics.

If you need market and business intelligence service in the vaccine market, please contact us at contact @ cbdmt.com.

CBDM.T® - Market and Business Intelligence- is a market and business intelligence company with offices in France, Switzerland and Israel. As an advisory services company, CBDM.T® boosts companies to develop revenue and growth by providing business and marketing services in the life science and biotech markets (market surveys, market scouting, business development and strategic supports).

For more information:

CBDM.T® Market and Business Intelligence
88-90 rue de la Mare
Fr-75020 Paris - France
Tel : +33 1 4474 7957
Email: contact @ cbdmt.com
Web site: CBDM.T®

CBDM.T® - Israel
POBox 6235
Netanya - 42490 - Israel
Tel: +972 52 3316190

To contact Philippe Tramoy directly

Next review: marine biotechnology - microalgae market

Our last focus:
White Biotechnology
Red Biotechnology
Green Biotechnology
Pharmaceutical Industry
Outsourcing In The Pharmaceutical Industry
Biofuels

###

Read the full story at http://www.prweb.com/releases/vaccines/cbdmt/prweb2314824.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
2. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
3. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
4. CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market
5. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market
6. Sinobiopharma, Inc. Appoints New Director of Marketing
7. Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market
8. Beacon Equity Issues Trade Alerts on Market Movers: CAH, LEAP, FISV, PBG, ARNA, LEN
9. Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications
10. VisualSonics to Sell Mauna Kea Technologies Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market
11. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBDM.T, The Market and Business Intelligence Company Reviews The Vaccine Market
(Date:2/11/2016)... 11, 2016 Non-profit Consortium Aims to ... to Support Research and Discovery --> ... an ambitious plan to sequence 100,000 individuals. It is intended ... at least 7 of North and East Asian countries. ... phase, the project will focus on creating phased reference genomes ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
(Date:2/11/2016)... Feb. 11, 2016  Dovetail Genomics™ LLC today announced ... program for a planned metagenomic genome assembly service. ... metagenomic genome assembly method in a talk on Friday, ... & Technology conference in Orlando, Fla. ... complex datasets is difficult. Using its proprietary ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem Cells Group, ... Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection and other biological ... Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, ...
Breaking Biology Technology:
(Date:2/10/2016)... India , February 10, 2016 /PRNewswire/ ... --> According to 2016 iris recognition ... identification iris recognition is more widely accepted ... available with both fingerprint and iris recognition ... the user to avoid purchasing two individual ...
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 /PRNewswire/ ... facilities are primarily focused on medical screening ... measure point-of-care parameters. Wearable devices that facilitate ... user,s freedom of movement are being bolstered ... for human biomedical signal acquisition coupled with ...
Breaking Biology News(10 mins):